Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 894 results for "glaxo"

SKANSKA : builds new laboratory facilities in Pennsylvania, US...

Skanska has signed a contract with GlaxoSmithKline (GSK) to renovate their lab and office space in Upper Providence, Pennsylvania, USA. The contract is worth USD 45M, about SEK 380M, which will be included in the order bookings for Skanska USA ... 4 Traders, 2 hours ago
[x]  

871 images for glaxo

Ticker Report, 1 day ago
FiercePharma, 2 days ago
Business Insider UK, 23 hours ago
reutersmedia.net, 2 days ago
Yahoo! India, 2 days ago
Dotemirates.com, 1 week ago
American Banking News, 1 week ago
HakiPensheni Monitor Online, 5 days ago
HakiPensheni Monitor Online, 5 days ago
World Pharma News, 1 week ago
Ticker Report

Kanaly Trust Co Sells 4,209 Shares of GlaxoSmithKline PLC (GSK)

Kanaly Trust Co reduced its position in GlaxoSmithKline PLC (NYSE:GSK) by 6.8% during the third quarter, Holdings Channel reports. The fund owned 57,548 shares of the pharmaceutical company's stock after selling 4,209 shares during the period.
 Mideast Time4 hours ago GlaxoSmithKline PLC (GSK) Stake Raised by Trust Co. of Virginia VA  Ticker Report1 day ago GSK, Innoviva seek EU nod for triple combo inhaled therapy  MassDevice2 days ago Glaxo files marketing application in Europe for inhaled triple combo COPD therapy  Seeking Alpha5 days ago
[x]  
Business Insider UK

Scotland could get a second independence referendum after Brexit

Scotland's First Minister Nicola Sturgeon visiting a GlaxoSmithKline office in Irvine, Scotland. Jeff J Mitchell/ Scotland could be offered a second referendum on independence from the UK, but only after Brexit has completed, according to a report ...
 Business Insider UK23 hours ago
American Banking News

GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at JPMorgan Chase & Co.

JPMorgan Chase & Co. reissued their neutral rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report released on Tuesday morning. The brokerage currently has a GBX 1,800 ($22.87) price target on the stock. Several other equities ...
 Zolmax News17 hours ago Goldman Sachs Group Inc. Reaffirms Buy Rating for GlaxoSmithKline PLC (GSK)  WKRB News22 hours ago GlaxoSmithKline plc (GSK) Given a GBX 1,760 Price Target at Deutsche Bank AG  Zolmax News1 day ago GlaxoSmithKline plc's (GSK) Buy Rating Reiterated at Goldman Sachs Group Inc.  SleekMoney1 day ago
[x]  
Motley Fool

Has GlaxoSmithKline Finally Turned the Corner?

Yet hope springs eternal -- and there's good reason to be hopeful about Glaxo's future. Let's check under the hood. With Advair's patent expiry, GlaxoSmithKline has been fighting a rearguard action to retain market share by cutting prices. (This ...
 Motley Fool1 day ago
PharmaVOICE

Relvar Ellipta receives Japanese approval to treat patients with COPD

GlaxoSmithKline plc (GSK) and Innoviva, Inc. announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Relvar Ellipta (fluticasone furoate/vilanterol 100/25 mcg) for the relief of various symptoms with chronic ...
 PharmaBiz3 days ago GSK seeks EU approval for inhaled triple combo COPD therapy  Pharmaceutical Business Review2 days ago Expanded use of Glaxo's Relvar Ellipta OK'd in Japan  Seeking Alpha5 days ago BRIEF-GSK's lung drug gains approval in Japan  Reuters UK6 days ago
[x]  

J&J's $26 Billion Swiss Drugs Experiment

Jean-Pierre Garnier is facing his biggest corporate challenge since stepping down as CEO of GlaxoSmithKline Plc in 2008. As chairman of Actelion Ltd., it's up to him to ensure the biotech's shareholders aren't left shortchanged after a takeover ...
 Bloomberg2 days ago J&J Conducts a $26 Billion Swiss Boardroom Experiment: Gadfly  Swiss Info2 days ago Johnson & Johnson's $26 Billion Swiss Drugs Experiment  BioSpace2 days ago

Better buy: GlaxoSmithKline plc vs Shire plc

On the face of it, GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) are both very similar; large, globe-spanning pharmaceutical companies with cutting-edge treatments for a range of diseases. But in fact the two companies are taking very, very ...
 Yahoo! Finance UK and Ireland2 days ago

How to Buy GlaxoSmithKline at a 15% Discount

 TheStreet.com5 days ago
Yahoo! Finance

NICE recommends GSK's new injectable asthma drug Nucala

UK's National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline's (GSK) new injectable asthma drug Nucala (Mepolizumab) for use in the country's state-run health service in the most severe patients. The drug has been ...
 Pharmaceutical Technology5 days ago What Smart Money Thinks About GlaxoSmithKline plc (ADR) (GSK)  Yahoo! Finance3 days ago GSK gets once-rejected asthma med Nucala past England's cost watchdogs  FiercePharma6 days ago GlaxoSmithKline Plc (NYSE:GSK) Targeting Blockbuster Sales With Shingles Vaccine On EU Approval  Pharmacy Choice1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less